CN Patent

CN117715644A — 纯孕激素口服避孕

Assigned to Navad Life Sciences Pte Ltd · Expires 2024-03-15 · 2y expired

What this patent protects

本发明涉及一种提供纯孕激素避孕的方法。该方法由向期望避孕的人类对象口服施用片剂达至少28天的治疗期组成，所述片剂由约0.115mg至约0.145mg的左炔诺孕酮(LNG)和和一种或多种药学上可接受的赋形剂组成。

USPTO Abstract

本发明涉及一种提供纯孕激素避孕的方法。该方法由向期望避孕的人类对象口服施用片剂达至少28天的治疗期组成，所述片剂由约0.115mg至约0.145mg的左炔诺孕酮(LNG)和和一种或多种药学上可接受的赋形剂组成。

Drugs covered by this patent

Patent Metadata

Patent number: CN117715644A
Jurisdiction: CN
Classification: —
Expires: 2024-03-15
Drug substance claim: No
Drug product claim: No
Assignee: Navad Life Sciences Pte Ltd
Source: FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.